This mutational signature did not fit an MMR deficiency–only model (signature 6 or cluster 2) that largely lacks C>A mutations or a germline POLE mutation model (signature 10 or cluster 3) that has C>A mutations almost exclusively in the context of TpCpT. This evidence concerns the gene POLE and mismatch repair cancer syndrome 1.